Journal of Antimicrobial Chemotherapy

Article	Citations
Remdesivir retreatment: another unproven intervention for COVID-19	94
In vitroantibiotic activity against intraosteoblasticStaphylococcus aureus: a narrative review of the literature	86
Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19	80
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection	63
An XDR Proteus vulgaris isolate hosting a novel blaNDM-1- and armA-carrying plasmid	61
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells	60
A paediatric hospital care AMC report for Northern Ireland	59
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence	57
The case for ‘conservative pharmacotherapy’—authors’ response	48
National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018	43
Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial	42
Recognition and management of clinically significant drug–drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionna	42
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting	40
A genetic cluster of OXA-244 carbapenemase-producing Escherichia coli ST38 with putative uropathogenicity factors in the Netherlands	40
Integrase inhibitors in children and adolescents: clinical use and resistance	40
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark	39
In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany	39
Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection	38
No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study	36
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort	34
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study	34
In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020–2023	33
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study	33
Fluoroquinolones and the risk for incidental seizures: a comparative retrospective study	32
Clinical exposure–response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model	32

BSAC Vanguard Series: Clean water—the world’s best medicine for disease and drug-resistant infection	32
Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model	31
Healthcare-associated NDM-1-producing Enterobacter hormaechei subsp. xiangfangensis clone ST136 emerging as pathogen of companion animals in Brazil	30
Increasing trend of antimicrobial resistance inShigellaassociated with MSM transmission in Barcelona, 2020–21: outbreak of XRDShigella sonneiand dissemination of ESBL-producingShigell	30
Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches	30
Cerebrospinal fluid concentration of foscarnet in patients with HHV-6 encephalitis after haematopoietic stem cell transplantation	29
Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization	29
Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases	29
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels	29
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype	28
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man	28
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine	28
Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials—authors’ response	28
Correction to: Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomon	27
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains	27
Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients	27
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation—authors’ response	27
Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery	27
Liposomal amphotericin B—the future	27
Post-report antibiotic initiation following community non-sterile-site microbiology results: an opportunity for labs to lead stewardship?	26
Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016–20	26
Comment on: Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU	26
Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions	26
Affinity of cefotiam for the alternative penicillin binding protein PBP3SAL used by Salmonella inside host eukaryotic cells	25
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinicalNeisseria gonorrhoeaeisolates from 25 European countries, 2018	25
Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections	25
Rapid meropenem/vaborbactam NP test for detecting susceptibility/resistance in Enterobacterales	25
Comment on: The case for ‘conservative pharmacotherapy’	24
Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study	24
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching—authors’ response	24
Detection of blaNDM-1 in Moellerella wisconsensis from mutton, China	24
Host stress hormone norepinephrine reduces in vitro activity of aminoglycoside against carbapenemase-producing Enterobacterales	24
Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections	24
Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance	24
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model	23
Co-location of the oxazolidinone resistance poxtA2 and cfr(D) genes on a multiresistance plasmid from a porcine Streptococcus dysgalactiae subsp. equisimilis, Italy	23
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance	23
Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand	23
The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic	23
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU—authors’ response	23
Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas’ disease	23
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients	23
The effect of novel aromatic heterocycle substituted aminamidine derivatives on Necator americanus	22
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study	22
Estimating the impact of cefuroxime versus cefazolin and amoxicillin/clavulanate use on future collateral resistance: a retrospective comparison	22
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study	22
Emerging resistance inStaphylococcus epidermidisduring dalbavancin exposure: a case report andin vitroanalysis of isolates from prosthetic joint infections	21
Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain	21
Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level	21
Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipient	21

Nosocomial dissemination of blaIMP-4 among Klebsiella pneumoniae by horizontal gene transfer and clonal spread: the epidemic IncN plasmids and the emerging high-risk IMP-4-producing ST10	21
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020–21	21
Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptib	21
Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region	20
Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli	20
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient	20
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations	20
Comment on: A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections	20
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus	20
Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?	20
Ceftazidime/avibactam serum concentration in patients on ECMO	19
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections—authors’ resp	19
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine	19
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs)	19
Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment	19
Clonal dissemination of MDR Pasteurella multocida ST79 in a small Swiss veal calf farm with high use of antibiotics	19
Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay	19
Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France	19
Saliva-based linezolid monitoring on a mobile UV spectrophotometer	19
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence	18
BSAC Vanguard Series: Tracking the global rise of antimicrobial resistance	18
Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study	18
Comment on: The case for ‘conservative pharmacotherapy’	18
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals	18
High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types	18
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies	18
Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas’ disease	18
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations	18
The case for ‘conservative pharmacotherapy’—authors’ response	18
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort	18
Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, a	18
Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time–kill experiments: agreement with in silico predictions	17
Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA	17
Does calculation method matter for targeting vancomycin area under the curve?	17
The comparison of the quality of selected brands of antibiotics in Tanzania sourced from different geographical regions	17
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study	17
A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gen	17
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco	17
Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation	17
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study	17
A drug candidate for Alzheimer’s and Huntington’s disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides	16
Distribution and expression of the aac(6′)-Im (aacA16) aminoglycoside resistance gene	16
Unmet needs and practical solutions in the management of invasive mould infections in Asia	16
Correction to: Advances in antibacterial treatment of adults with high-risk febrile neutropenia	16
Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species	16
The use of continuous electronic prescribing data to infer trends in antimicrobial consumption and estimate the impact of stewardship interventions in hospitalized children	16
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far	16
Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children’s hospitals in Japan	16
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis an	16
Reporting antimicrobial susceptibilities and resistance phenotypes inStaphylococcusspp.: a nationwide proficiency study	16
Thiocillin and micrococcin exploit the ferrioxamine receptor of Pseudomonas aeruginosa for uptake	16
Fostemsavir to overcome drug–drug interactions in heavily treatment-experienced people with HIV and cancer	16
Beyond the FIC index: the extended information from fractional inhibitory concentrations (FICs)	16
Characterization of a prophage and a defective integrative conjugative element carrying the optrA gene in linezolid-resistant Streptococcus dysgalactiae subsp. equisimilis isolate	16
In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration	16
Extensively resistant Acinetobacter baumannii isolate RCH52 carries several resistance genes derived from an IncC plasmid	16
Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis	16
Variation in approaches to antimicrobial use surveillance in high-income secondary care settings: a systematic review	16
Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus	16
The emergence of the ceftriaxone-resistantNeisseria gonorrhoeaeFC428 clone by transfer of resistance from an oralNeisseria subflavareservoir of resistance	16
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults	15
Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings	15
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis	15
Rapid selection of a cefiderocol-resistantEscherichia coliproducing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor	15
Diagnosis-linked antibiotic prescribing quality indicators: demonstrating feasibility using practice-based routine primary care data, reliability, validity and their potential in antimicrobial steward	15
Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?	15
Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study	15
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria—authors’ response	15
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence ofClostridioides difficileinfection: a propensity score analysis	15
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia	15
Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model	15
Novel macrolide-lincosamide-streptogramin B resistance gene erm(54) in MRSA ST398 from Germany	15
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis	15
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews	15
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates	15
Temocillin for febrile urinary tract infections caused by ESBL-producing Enterobacteriaceae in children: a monocentric exposed/non-exposed study	15
Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection	15
Outcome selection in primary care antimicrobial stewardship research	14
Healthcare-associated vanA-positive Enterococcus faecium clone ST612 emerging as pathogen of companion animals in Brazil	14
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients–authors’ response	14

Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam	14
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)	14
Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guideline	14
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV	14
Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance	14
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a ne	14
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance	14
Oral ciprofloxacin activity against ceftriaxone-resistantEscherichia coliin anin vitrobladder infection model	14
Differences in antibiotic use between COPD and non-COPD residents based on the health information system	14
Measuring the impacts of the Using Antibiotics Wisely campaign on Canadian community utilization of oral antibiotics for respiratory tract infections: a time-series analysis from 2015 to 2019	14
Low CD4 counts predict excessive weight gains during first-line treatment for HIV	14
Community spread and acquisition of clinically relevant Escherichia coli harbouring blaNDM among healthy Japanese residents of Yangon, Myanmar	14
Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance	14
Syndromic testing for the diagnosis of infectious diseases: the right test if used for the right patient	14
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis	14
Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs	14
Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring	14
Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study—authors’ response	14
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates	14
Influence of the COVID-19 pandemic on the defined daily dose of antimicrobials in patients requiring elective and emergency surgical procedures	14
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020	14
Specific mutations in the HIV-1 G-tract of the 3′-polypurine tract cause resistance to integrase strand transfer inhibitors	14
A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004–20 in Spain	14
The primary pharmacology of ceftazidime/avibactam: resistancein vitro	14
Novel approach using automated target enrichment enables culture-independent accurate whole-genome sequencing of Neisseria gonorrhoeae directly from clinical urogenital and extragenital specime	13
An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients	13
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate	13
Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China	13
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2	13
A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum	13
Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study	13
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France	13
Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case–control study	13
Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli	13
A novel Bacteroides metallo-β-lactamase (MBL) and its gene (crxA) in Bacteroides xylanisolvens revealed by genomic sequencing and functional analysis	13
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48	13
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study	13
Comment on: MDR carbapenemase-producingKlebsiella pneumoniaeof the hypervirulence-associated ST23 clone in Poland, 2009–19	13
Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?	13
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)	13
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina	13
Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium	13
Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, acce	13
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo	13
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes	13
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain	13
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals	13
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance	13
Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa	13
Comparative in vitro efficacy of AR-12 derivatives against Streptococcus pyogenes	13
Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study	13
WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing	13
Why we prescribe antibiotics for too long in the hospital setting: a systematic scoping review	12
In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius	12
Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testin	12
Strategies to reduce antimicrobials in livestock and aquaculture, and their impact under field conditions: a structured scoping literature review	12
Towards optimization of ceftazidime dosing in obese ICU patients: the end of the ‘one-size-fits-all’ approach?	12
Implication of genotypes for prognosis of Candida glabrata bloodstream infections	12
Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model	12
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study	12
Evaluation of the RESIST ACINETO multiplex immunochromatographic assay for detection of OXA-23-like, OXA-40/58-like and NDM carbapenemase production in Acinetobacter baumannii	12
Genomic analyses of Staphylococcus aureus isolated from yaks in Ganzi Tibetan Autonomous Prefecture, China	12
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run	12
Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation	12
Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records	12
Neisseria gonorrhoeae treatment failure to the recommended antibiotic regimen—Québec, Canada, 2015–19	12
Comment on: Deleterious effects of a combination therapy using fluoroquinolones and tetracyclines for the treatment of Japanese spotted fever: a retrospective cohort study based on a Japanese hospital	12
Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring blaNDM-1 in an IncC plasmid	12
Off-label use of dalbavancin in children: a case series	12
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species	12
In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation	12
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review	12
Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus	12
Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective	12
A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii	12
Regulation of bla system in ST59-related oxacillin-susceptible mecA-positive Staphylococcus aureus	12
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study	12
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV	12
Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?	12
Metabolic pathways and antimicrobial peptide resistance in bacteria	12
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection	12
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy	12
Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-anal	12
Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance	12
Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision	12
In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus	12
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation	11
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)	11
SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase	11
Point-of-care tests to manage acute respiratory tract infections in primary care: a systematic review and qualitative synthesis of healthcare professional and patient views	11
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases	11
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan	11
Critical assessment of commercially available microtitre panels for antimicrobial susceptibility testing of veterinary pathogens	11
Use of echinocandins combined with clindamycin in Pneumocystis pneumonia: a case series of 14 patients	11
Identifying AWaRe indicators for appropriate antibiotic use: a narrative review	11